Steven C. Quay
President & CEO · ATOSSA THERAPEUTICS, INC.
IndividualBuying only
- 2025
- Mar 31, 2026
- 5
Other insiders active in the same sector
No other insider has filed at Steven C. Quay's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Ugur Sahin - $84.23M in BNTX purchases and sales in the last 12 months
- Mark T. Bertolini - $82.60M in OSCR purchases and sales in the last 12 months
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Steven C. Quay?
Steven C. Quay is a corporate insider, tracked as President & CEO of ATOSSA THERAPEUTICS, INC. (ATOS). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Steven C. Quay last file a Form 4?
The most recent primary Form 4 on record is dated 31 March 2026, one of 5 filings going back to 2025.
Has Steven C. Quay been buying or selling stock?
Recorded transactions: 1 open-market purchase ($10K) and 0 open-market sales across all tracked filings.
